GC
TRIL

Guggenheim Capital’s Trillium Therapeutics Inc. TRIL Stock Holding History

Guggenheim Capital’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-72,367
Closed -$1.27M – 2291
2021
Q3 		$1.27M Buy
72,367
+18,715
+35% +$329K 0.01% 1294
2021
Q2 		$520K Buy
53,652
+2,455
+5% +$23.8K ﹤0.01% 1808
2021
Q1 		$550K Buy
51,197
+24,415
+91% +$262K ﹤0.01% 1669
2020
Q4 		$394K Buy
+26,782
New +$394K ﹤0.01% 1734